Mammosphere Assay

These culture conditions limit attachment and reduce the contribution of cells that depend on standard adherent growth. Cells that remain viable and retain sufficient self-renewal capacity can continue proliferating as three-dimensional clusters. This selective environment helps enrich for differences in stem-like behavior, allowing researchers to examine which cell populations maintain sphere-forming capacity under restrictive conditions.

Sphere-forming efficiency provides a comparative measure of how readily a cell population generates mammospheres under the assay conditions. Higher or lower values can indicate differences in self-renewal or sphere-forming capacity between samples. Researchers can therefore use the readout to evaluate changes associated with cancer-related pathways, genetic alterations, or exposure to experimental treatments.

Mammospheres provide a three-dimensional context for examining cell behaviors associated with stem-like populations, including continued proliferation under conditions that limit attachment. In cancer research, this makes the assay useful for investigating cellular programs that support tumor initiation and maintenance. The resulting behavior offers a functional comparison between cell populations rather than relying only on descriptive markers.

Researchers begin with dissociated mammary epithelial or tumor cells and place them in serum-free culture conditions that limit attachment. The cells are then maintained so that those with adequate survival and self-renewal capacity can proliferate into spherical clusters. Investigators assess sphere formation and use sphere-forming efficiency to compare the tested cell populations or experimental conditions.

The assay allows researchers to compare sphere-forming capacity after applying a drug treatment or introducing a genetic change. A difference in the resulting efficiency can indicate that the intervention affects cellular properties associated with self-renewal or sphere formation. This approach helps identify treatments or alterations that influence stem-like cancer cell behavior.

By measuring behavior linked to stem-like cell populations, the assay helps connect self-renewal capacity with broader cancer processes. Researchers can use it to investigate pathways that support tumor initiation and maintenance, then examine whether these properties change in contexts related to therapeutic resistance or disease progression. It therefore links a controlled cell-based outcome with clinically relevant cancer biology.